Skip to main content
SpringerLink
Log in

Impact of the Number and Extent of Positive Lymph Nodes in 200 Patients with Thoracic Esophageal Squamous Cell Carcinoma after Three-field Lymph Node Dissection

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Subtotal esophagectomy with three-field lymph node dissection (3FLD) has been reported to improve survival in patients with thoracic esophageal squamous cell carcinoma (SCC). The purpose of this study was to evaluate the prognostic impact of the extent and number of positive lymph nodes for long-term survival of patients who underwent 3FLD.

Methods

From January 1983 to December 2002, a total of 200 patients with thoracic esophageal SCC underwent 3FLD without any neoadjuvant therapy. The prognostic impact of the extent and number of positive lymph nodes was evaluated by both univariate and multivariate analysis.

Results

The extent of positive nodes associated with a 5-year survival were as follows: none, 69%; one-field, 50%; two-field, 29%; and three-field, 11%. The number of positive nodes associated with 5-year survival were as follows: single node, 65%; two-nodes, 51%; and more than three-nodes, 20%. Among patients with cervical lymphatic spreading, patients with upper tumors showed significantly better survival than patients with lower tumors (P = 0.036). Multivariate analysis indicated that number of positive nodes and the abdominal node status were independent prognostic factors among lymph node status.

Conclusions

Together, number and extent of positive lymph nodes can be considered an independent predictor of a high risk of recurrence. Although cervical lymphatic spreading was risk factor for worse survival, patients with upper tumors may have survival benefit after cervical lymph node dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.
Figure 3.

Similar content being viewed by others

References

  1. Isono K, Onoda S, Ishikawa T, et al. Studies on the causes of deaths from esophageal carcinoma. Cancer 1982;49:2173

    Article  PubMed  CAS  Google Scholar 

  2. Isono K, Ochiai T, Okuyama K, et al. The treatment of lymph node metastasis esophageal cancer by extensive lymphadenectomy. Jpn J Surg 1990;20:151

    Article  PubMed  CAS  Google Scholar 

  3. Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364

    PubMed  CAS  Google Scholar 

  4. Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275

    Article  PubMed  CAS  Google Scholar 

  5. Nakagawa S, Kanda T, Kosugi S, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205

    Article  PubMed  Google Scholar 

  6. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous cell esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225

    Article  PubMed  CAS  Google Scholar 

  7. Baba M, Aikou T, Yoshinaka H, et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994;219:310

    PubMed  CAS  Google Scholar 

  8. Altoki N, Kent M, Ferrara C, et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177

    Article  Google Scholar 

  9. Shimada H, Ochiai T, Okazumi S, et al. Clinical benefits of steroid on the surgical stress in patients with esophageal cancer. Surgery 2000;128:791

    Article  PubMed  CAS  Google Scholar 

  10. Shimada H, Okazumi S, Mtsubara H, et al. Impact of steroid therapy on postoperative course and survival in patients with thoracic esophageal carcinoma. Esophagus 2004;1:89

    Article  Google Scholar 

  11. Okazumi S, Ochiai T, Shimada H, et al. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004;17:159

    Article  PubMed  CAS  Google Scholar 

  12. Sobin LH, Wittekind CH (editors). UICC TNM Classification of Malignant Tumor, 6th ed. New York, John Wiley & Sons, Inc., 2002

    Google Scholar 

  13. Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24

    Article  PubMed  Google Scholar 

  14. Igaki H, Kato H, Tachimori Y, et al. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 2003;133:368

    Article  PubMed  Google Scholar 

  15. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003;24:4592

    Article  Google Scholar 

  16. Natsugoe S, Yoshinaka H, Shimada M, et al. Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg 1999;229:62–66

    Article  PubMed  CAS  Google Scholar 

  17. Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005;103:148–156

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a grant-in-aid from the Ministry of Education, Science and Culture of Japan (21st Century Center of Excellence Program).

Author information

Authors and Affiliations

  1. Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan

    Hideaki Shimada MD, Shin-ichi Okazumi MD, Hisahiro Matsubara MD, Yoshihiro Nabeya MD, Tooru Shiratori MD, Takanori Shimizu MD, Kiyohiko Shuto MD, Hideki Hayashi MD & Takenori Ochiai MD

  2. Department of Academic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuou-Ku, Chiba, 260-8677, Japan

    Hideaki Shimada MD

Authors
  1. Hideaki Shimada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shin-ichi Okazumi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hisahiro Matsubara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiro Nabeya MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tooru Shiratori MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takanori Shimizu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kiyohiko Shuto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hideki Hayashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takenori Ochiai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideaki Shimada MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, H., Okazumi, Si., Matsubara, H. et al. Impact of the Number and Extent of Positive Lymph Nodes in 200 Patients with Thoracic Esophageal Squamous Cell Carcinoma after Three-field Lymph Node Dissection. World J. Surg. 30, 1441–1449 (2006). https://doi.org/10.1007/s00268-005-0462-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-0462-6

Keywords

Search

Navigation